News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178,655 Results
Type
Article (8103)
Company Profile (7)
Press Release (170545)
Section
Business (57812)
Career Advice (524)
Deals (10315)
Drug Delivery (22)
Drug Development (24459)
Employer Resources (31)
FDA (4229)
Job Trends (4389)
News (94709)
Policy (7367)
Tag
Academia (474)
Accelerated approval (2)
Adcomms (4)
Allergies (40)
Alliances (7192)
ALS (50)
Alzheimer's disease (441)
Antibody-drug conjugate (ADC) (56)
Approvals (4292)
Artificial intelligence (118)
Autoimmune disease (17)
Automation (9)
Bankruptcy (110)
Best Places to Work (3986)
BIOSECURE Act (3)
Biosimilars (49)
Biotechnology (11)
Bladder cancer (57)
Brain cancer (14)
Breast cancer (174)
Cancer (1299)
Cardiovascular disease (89)
Career advice (428)
CAR-T (65)
Cell therapy (190)
Cervical cancer (10)
Clinical research (21686)
Collaboration (371)
Compensation (256)
Complete response letters (5)
COVID-19 (698)
CRISPR (15)
C-suite (77)
Cystic fibrosis (29)
Data (1333)
Depression (17)
Diabetes (121)
Diagnostics (1812)
Digital health (10)
Diversity, equity & inclusion (8)
Drug discovery (43)
Drug pricing (23)
Drug shortages (6)
Duchenne muscular dystrophy (35)
Earnings (45452)
Editorial (10)
Employer branding (5)
Employer resources (27)
Events (28633)
Executive appointments (313)
FDA (4916)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (370)
Gene editing (44)
Generative AI (5)
Gene therapy (140)
GLP-1 (311)
Government (1147)
Grass and pollen (4)
Guidances (138)
Healthcare (5254)
Huntington's disease (4)
IgA nephropathy (9)
Immunology and inflammation (55)
Indications (15)
Infectious disease (779)
Inflammatory bowel disease (67)
Inflation Reduction Act (1)
Influenza (29)
Intellectual property (33)
Interviews (93)
IPO (6655)
IRA (8)
Job creations (710)
Job search strategy (380)
Kidney cancer (10)
Labor market (8)
Layoffs (136)
Leadership (3)
Legal (1390)
Liver cancer (28)
Lung cancer (198)
Lymphoma (100)
Machine learning (2)
Management (10)
Manufacturing (98)
MASH (41)
Medical device (3625)
Medtech (3625)
Mergers & acquisitions (3932)
Metabolic disorders (336)
Multiple sclerosis (46)
NASH (7)
Neurodegenerative disease (44)
Neuropsychiatric disorders (10)
Neuroscience (692)
NextGen: Class of 2025 (1410)
Non-profit (1041)
Now hiring (7)
Obesity (177)
Opinion (45)
Ovarian cancer (39)
Pain (40)
Pancreatic cancer (41)
Parkinson's disease (67)
Partnered (2)
Patents (69)
Patient recruitment (47)
Peanut (24)
People (5909)
Pharmaceutical (2)
Pharmacy benefit managers (3)
Phase I (5683)
Phase II (9117)
Phase III (8494)
Pipeline (1001)
Policy (24)
Postmarket research (953)
Preclinical (1874)
Press Release (12)
Prostate cancer (63)
Psychedelics (7)
Radiopharmaceuticals (84)
Rare diseases (146)
Real estate (899)
Recruiting (12)
Regulatory (5635)
Reports (15)
Research institute (439)
Resumes & cover letters (88)
Rett syndrome (5)
RNA editing (1)
RSV (28)
Schizophrenia (36)
Series A (59)
Series B (42)
Service/supplier (1)
Sickle cell disease (24)
Special edition (5)
Spinal muscular atrophy (70)
Sponsored (7)
Startups (589)
Stomach cancer (4)
Supply chain (30)
Tariffs (12)
The Weekly (5)
Vaccines (261)
Venture capitalists (17)
Weight loss (114)
Women's health (11)
Worklife (4)
Date
Today (102)
Last 7 days (677)
Last 30 days (1898)
Last 365 days (15446)
2025 (6609)
2024 (13654)
2023 (12586)
2022 (16375)
2021 (16028)
2020 (14213)
2019 (12463)
2018 (9249)
2017 (8431)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
Location
Africa (193)
Alabama (11)
Alaska (2)
Arizona (43)
Arkansas (4)
Asia (10766)
Australia (1797)
California (3142)
Canada (832)
China (248)
Colorado (134)
Connecticut (170)
Delaware (119)
Europe (25909)
Florida (374)
Georgia (96)
Idaho (15)
Illinois (253)
India (8)
Indiana (139)
Iowa (4)
Japan (111)
Kansas (24)
Kentucky (8)
Louisiana (6)
Maine (25)
Maryland (334)
Massachusetts (2395)
Michigan (67)
Minnesota (147)
Mississippi (1)
Missouri (37)
Montana (7)
Nebraska (2)
Nevada (35)
New Hampshire (24)
New Jersey (884)
New Mexico (7)
New York (856)
North Carolina (362)
North Dakota (4)
Northern California (1395)
Ohio (88)
Oklahoma (3)
Oregon (8)
Pennsylvania (572)
Puerto Rico (2)
Rhode Island (6)
South America (288)
South Carolina (5)
Southern California (1116)
Tennessee (50)
Texas (478)
United States (11104)
Utah (86)
Virginia (84)
Washington D.C. (15)
Washington State (266)
West Virginia (1)
Wisconsin (49)
178,655 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ruvidar Demonstrates 7 Year Complete Response
Patient Diagnosed with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ Treated Once with Light-Activated Ruvidar(TM) Demonstrates 7 Year Complete Response
April 7, 2025
·
6 min read
Job Trends
7 Companies Hiring in Indiana
Looking for a biopharma job in Indiana? Check out the
BioSpace
list of seven companies hiring life sciences professionals like you.
March 27, 2025
·
1 min read
·
Angela Gabriel
Press Releases
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025 REVENUE +11.9%, EBITDA(1) +10.7%, ADJUSTED NET INCOME(2) +7.2%
May 8, 2025
·
19 min read
Press Releases
Travere Therapeutics to Participate at Upcoming Investor Conferences - May 7, 2025
May 8, 2025
·
1 min read
Press Releases
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
InflaRx to Report First Quarter 2025 Results on May 7, 2025
April 30, 2025
·
2 min read
Press Releases
Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement
April 7, 2025
·
6 min read
Press Releases
Malaria Vaccines Market Size to Reach USD 1,432.7 Mn by 2032, Growing at 12.7% CAGR, says Coherent Market Insights
April 11, 2025
·
1 min read
Press Releases
NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025
April 25, 2025
·
3 min read
Press Releases
FDA Roundup: March 7, 2025
March 10, 2025
·
2 min read
1 of 17,866
Next
